Clinical Trial Update: Treatment of Sequelae Caused by Severe Brain Injury With Autologous Adipose-derived Mesenchymal Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating autologous adipose-derived mesenchymal stem cells for sequelae of severe brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Autologous adipose-derived mesenchymal stem cells (adipose-derived mesenchymal stem cells)

Snippet

Sponsor: National Yang Ming Chiao Tung University | Conditions: The Sequelae Caused by Severe Brain Injury | Phase 1, Phase 2 | Status: COMPLETED